Therefore, we elucidated the role of the miR-130a-3p/GCNT4/TGF-β1/SMAD3 axis in gastric cancer genesis, which could provide potential therapeutic targets for gastric cancer involving both miR-130a-3p and GCNT4. Here, SMAD3 is linked to gastric cancer.